AstraZeneca Pharma India Company Description

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.

It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names.

The company also offers medicines for diabetes; and clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India.

AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

AstraZeneca Pharma India Limited

Country	India
Founded	1979
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	802
CEO	Praveen Akkinepally

Contact Details

Address: Manyata Embassy Business Park Bengaluru, 560045 India
Phone	91 80 6774 8000
Website	astrazeneca.in

Stock Details

Ticker Symbol	ASTRAZEN
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE203A01020
SIC Code	2834

Key Executives

Name	Position
Bhavana Agrawal	Whole-Time Director and Chief Financial Officer
Praveen Rao Akkinepally	MD and Director
Manasa R.	Company Secretary and Compliance Officer
Pankaj S Jain	Legal Head
Smita Saha	Vice President of Human Resources
Ayush Kumar Agarwal	Business Unit Head of Biopharmaceutical Business Unit
Vinay Sharma	Business Unit Head - Rare Disease unit
Amarpreet Kaur Ahuja	Country Human Resources Director
Srikanth B. S.	Site Lead, India Operations